1. Home
  2. VCEL vs FCNCP Comparison

VCEL vs FCNCP Comparison

Compare VCEL & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$40.79

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo First Citizens BancShares Inc.

FCNCP

First Citizens BancShares Inc.

N/A

Current Price

$18.36

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VCEL
FCNCP
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
N/A
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
VCEL
FCNCP
Price
$40.79
$18.36
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $57.75
N/A
AVG Volume (30 Days)
★ 408.0K
11.1K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 60.00
N/A
EPS
N/A
★ 97.95
Revenue
$276,259,000.00
★ $9,541,000,000.00
Revenue This Year
$19.40
N/A
Revenue Next Year
$18.24
N/A
P/E Ratio
★ N/A
$0.19
Revenue Growth
★ 16.45
N/A
52 Week Low
$28.95
$18.35
52 Week High
$49.32
$22.60

Technical Indicators

Market Signals
Indicator
VCEL
FCNCP
Relative Strength Index (RSI) 48.84 17.64
Support Level $33.21 N/A
Resistance Level $41.12 $21.39
Average True Range (ATR) 1.26 0.30
MACD 0.25 -0.06
Stochastic Oscillator 81.62 0.00

Price Performance

Historical Comparison
VCEL
FCNCP

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About FCNCP First Citizens BancShares Inc.

First Citizens is a US regional bank with total assets of around $237 billion as of June 30, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.

Share on Social Networks: